SafeSpace Global signs services agreement with Antidote Health Ventures for addiction treatment vertical
SAFESPACE GLOBAL CORPORATION
SAFESPACE GLOBAL CORPORATION SSGC | 0.00 |
- SafeSpace Global signed a master services agreement with Antidote Health Ventures to co-develop a new addiction treatment safety-monitoring vertical.
- The agreement sets a pilot framework for platform deployment, workflow refinement, support, configuration, installation responsibilities.
- The companies also executed a HIPAA-aligned business associate agreement covering limited PHI handling tied to non-clinical monitoring.
- SafeSpace plans to grant exclusivity in the vertical to its first partner once a final vertical-specific agreement is signed.
- Method Five Labs signed a non-binding LOI for a contingent equity investment of USD 1 million to USD 3 million at USD 0.2 per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Safespace Global Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606101731PRIMZONEFULLFEED9735241) on June 10, 2026, and is solely responsible for the information contained therein.
